CPT copyright 2022 American Medical Association. All rights reserved. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.


These Terms and Conditions (“Agreement”) govern your use of the Medvise software (“Software”) provided by Medvise Corp (“Company”). By accessing or using the Software, you agree to be bound by these terms. If you do not agree with any part of these terms, you may not use the Software.

About Medvise


a. The Company grants you a non-exclusive, non-transferable, revocable license to use the Software for its intended purpose.

b. You may not sublicense, distribute, lease, or modify the Software without prior written consent from the Company.

When we collect personal data about you

  • Enhance or improve User experience, our Site, or our Service.
  • Send emails and updates about Conclude, Process transactions.
  • Send emails about our Site or respond to inquiries.
  • Including news and requests for agreement to amended legal documents such as this Privacy Policy and our Terms of Service.
Company Liability:

If you enter into this agreement on behalf of a company, you hereby agree that the company is responsible under this Agreement for all actions and omissions conducted by its designated users of the Service.

Intellectual Property:

a. The Software and all associated intellectual property rights are owned by the Company and protected by copyright and other laws.
b. You acknowledge and agree that any feedback, suggestions, or ideas you provide to the Company regarding the Software may be used by the Company without any obligation to compensate you.

Privacy and Data Protection:

a. The Company collects and processes personal data in accordance with its Privacy Policy.
b. By using the Software, you consent to the Company’s collection, storage, and processing of personal data as described in the Privacy Policy.

Limitation of Liability:

a. The Company shall not be liable for any indirect, incidental, consequential, or punitive damages arising out of or in connection with the use of the Software.
b. In no event shall the Company’s total liability to you exceed the amount paid by you, if any, for accessing or using the Software.

By using our App, you acknowledge and agree that the information and services provided through the App are for general informational purposes only. We do not provide medical advice, diagnosis, or treatment. Users are solely responsible for their use of the App and any reliance on the information provided. Any decisions made based on information obtained through the App are at the user’s own discretion and risk.

You agree that we shall not be liable for any direct, indirect, incidental, special, consequential, or exemplary damages, including but not limited to, damages for loss of profits, goodwill, use, data, or other intangible losses, resulting from your use or inability to use the App or any unauthorized access to or use of our servers and/or any personal information stored therein.

You agree to indemnify and hold us, our affiliates, officers, directors, employees, agents, and partners harmless from and against any claims, demands, actions, liabilities, and settlements, including without limitation, reasonable legal and accounting fees, resulting from or alleged to result from your use of the App, your violation of these terms and conditions, or your violation of any rights of another party.

Users of the App understand and accept that the App is not a substitute for professional medical advice, diagnosis, or treatment. Users are solely responsible for their use of the App and any decisions made based on the information provided. We shall not be held liable for any consequences resulting from a user’s reliance on the App or its content.

We shall not be liable for any failure or delay in the performance of our obligations under this SLA or the WEB APP MEDVICE operation if such failure or delay is caused by events beyond our reasonable control, including, but not limited to, acts of nature, government actions, strikes, power outages, or other force majeure events.

We reserve the right to modify this SLA at our discretion, and any changes will be communicated to users through the App or our website. Continued use of the App after such changes constitutes acceptance of the modified SLA.

Users acknowledge that Medvise may involve interactions with third-party funders, including insurance providers and healthcare organizations, for purposes of payment and reimbursement. While we may facilitate or assist in the billing process by providing necessary documentation, we do not assume responsibility for the outcome of such billing or insurance claims. The responsibility for verifying coverage, submitting claims, and resolving billing disputes with funders or insurers rests solely with the user or their designated healthcare provider. Users should consult their insurance policies and healthcare providers for guidance on reimbursement, coverage, and claims processing. We do not guarantee the approval, accuracy, or timeliness of any insurance claims and disclaim any liability for claims processing or reimbursement-related issues. Users are encouraged to communicate directly with their funders or insurers for any billing or reimbursement concerns.


a. The Company reserves the right to terminate or suspend your access to the Software at any time without prior notice, for any reason or no reason.
b. Upon termination, your license to use the Software shall be revoked, and you must cease all use of the Software.

Governing Law:

a. This Agreement shall be governed by and construed in accordance with the laws of the state of Delaware, without regard to its conflict of laws principles.
b. Any disputes arising out of or in connection with this Agreement shall be submitted to the exclusive jurisdiction of the state and federal courts located in Delaware.